Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3–C9)
- 30 November 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (8) , 1409-1414
- https://doi.org/10.1016/0192-0561(92)90012-a
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitroInternational Journal of Immunopharmacology, 1992
- Interaction of anti-leprosy drugs with the rat serum complement systemImmunopharmacology, 1988
- In vitro inhibition of the classical pathway of human complement by polymyxin BBiochemical Pharmacology, 1987
- Effects of chloroquine on the serum complement systemImmunopharmacology, 1985
- In vitro inhibition of the activation of the human complement and coagulation systems by chloroquineInternational Journal of Immunopharmacology, 1985
- Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis.Published by Wiley ,1975
- Anti-complement effects of two anti-inflammatory agents: Niflumic and flufenamic acidsBiochemical Pharmacology, 1974